CARCINOMA ANAPLÁSICO DE TIREÓIDE – RELATO DE CASO
Resumo
Palavras-chave
Texto completo:
PDFReferências
Ragazzi M, Clarrocchi A, Sancisi V, Gandolfi G, Bisagni
A, Plana S. Update on Anaplastic Thyroid Carcinoma:
Morphological, Molecular, and Genetic Features of the
Most Agressive Thyroid Cancer. International Journal
of Endocrinology. 2014; 1:13.
Carvalho GA, Graf H. Carcinoma indiferenciado de
Tireóide. Arq Bras Endocrinol Metab. 2005; 49(5):719-
Dibelius G, Mehra S, Clain JB, Urken ML, Wenig BM.
Noninvasive Anaplastic Thyroid Carcinoma: Reporto f a
Case and Literature Review. Thyroid.
;24(8):1319-24.
Nachalon Y, Shavit SS, Bachar G, Shvero J, Limon D,
Popovtzer A. Aggressive Palliation and Survival in
Anaplastic Thyroid Carcinoma. JAMA OtolaryngologyHead
& Neck Surgery. 2015; 141(12):1128-32.
Keutgen XM, Sadowsko SM, Kebebew E. Management
of anaplastic thyroid câncer. Gland Surgery. 2015;
(1):44-51.
Leuchter I, Becker M, Mickel R, Dulguerov P. Horner’s
syndrome and thyroid neoplasms. ORL.
;64(1):49-52.
Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD,
Burman KD, Kebebew E, Lee NY, Nikiforov YE,
Rosenthal MS, Shah MH, Shaha AR, Tuttle RM,
American Thyroid Association Anaplastic Thyroid
Cancer Guidelines T. American Thyroid Association
guidelines for management of patients with anaplastic
thyroid cancer. Thyroid. 2012;22(11):1104-39.
McIver B, Hay ID, Giuffrida DF, Dvorak CE, Grant CS,
Thompson GB, van Heerden JA, Goellner JR. Anaplastic
thyroid carcinoma: a 50-year experience at a single
institution. Surgery. 2001;130(6):1028-34.
Dedecjus M, Tazbir J, Kaurzel Z, Lewinski A, Strozyk G,
Brzezinski J. Selective embolization of thyroid arteries
as a preresective and palliative treatment of thyroid
cancer. Endocr Relat Cancer. 2007;14(3):847-5
Ain KB, Egorin MJ, DeSimone PA. Treatment of
anaplastic thyroid carcinoma with paclitaxel: phase 2
trial using ninety-six-hour infusion. Collaborative
Anaplastic Thyroid Cancer Health Intervention Trials
(CATCHIT) Group. Thyroid. 2000;10(7):587-94
Yeung SC, Xu G, Pan J, Christgen M, Bamiagis A.
Manumycin enhances the cytotoxic effect of paclitaxel
on anaplastic thyroid carcinoma cells. Cancer Res.
;60(3):650-6.
Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T,
Worden FP. A phase II study of imatinib in patients with
advanced anaplastic thyroid cancer. Thyroid.
;20(9):975-80
Haghpanah V, Fallah P, Tavakoli R, Naderi M, Samimi
H, Soleimani M, Larijani B. Antisense-miR-21
enhances differentiation/apoptosis and reduces
cancer stemness state on anaplastic thyroid cancer.
Tumour Biol. 2015.
DOI: http://dx.doi.org/10.5380/rmu.v4i1.52253
DOI (PDF): http://dx.doi.org/10.5380/rmu.v4i1.52253.g32202
Apontamentos
- Não há apontamentos.